Showing 190 articles tagged

Early research shows immunotherapy's potential for one type of aggressive prostate cancer

4 Sep 2018

The Institute of Cancer Research has discovered a genetic mutation in samples of some men's tumours that could make them particularly susceptible to immunotherapy treatment. The researchers are now committed to running clinical trials to prove if their theory is right.

Largest trial of HIFU focal therapy shows early promise

5 Jul 2018

A five-year early-stage study of high-intensity focused ultrasound resulted in tumour progression being halted in men with intermediate-risk, localised prostate cancer. But more evidence is needed to prove its benefits hold up against existing treatment options and for all men with the disease.

Immune cells breakthrough raises hopes for delaying treatment resistance

27 Jun 2018

Preventing resistance to hormone therapy is a key goal for researchers trying to improve prostate cancer treatment. Now, research funded by us – thanks to your donations – has revealed that the immune system could have a part to play.

Access to mpMRI before biopsy increasing but parts of UK are still 'appalling'

19 Jun 2018

We're calling on the NHS to make rollout of the revolutionary diagnostic technique for prostate cancer a priority, after new data shows a huge variation in the availability and quality of mpMRI scans across the UK. Check out how your local hospitals are performing in our online map, and find out more about the first clinical consensus on mpMRI we've helped to create.

Behind the Headlines: The prostate cancer 'spit test'

12 Jun 2018

Across the papers today is news of a 'spit test' to help diagnose prostate cancer. It’s a promising step forward in genetics, but we still need better tests for diagnosis.

New type of immune treatment shows early promise for advanced prostate cancer

5 Jun 2018

An early-stage trial of the immunotherapy drug, pembrolizumab, has proven it to be effective for a small number of men with incurable disease. We take a closer a look at how it works and what we're doing to bring the benefits of immunotherapy to many more men with prostate cancer.

New type of ultrasound shows promise at spotting aggressive prostate cancer in study we funded

23 Apr 2018

New research backed by us and the Movember Foundation has shown that a type of ultrasound scan, which can detect the stiffness of the prostate, may be able to spot aggressive cancer.

Genetics researchers find new avenues for prostate cancer treatments

17 Apr 2018

An international group of researchers has identified dozens more genes that are potentially involved in the growth of prostate cancer. This could lead to new ways of treating the disease.

How your support led to Theresa May’s £75 million research promise and why we can't stop now

11 Apr 2018

BLOG: After Theresa May’s announcement of £75 million for prostate cancer research, Ian le Guillou looks at how government and charity funding work together and how your support is critical to bag the big bucks needed for major breakthroughs.

Could exercise prevent prostate cancer spreading to the bones? We’re on the case

5 Apr 2018

A new research project, grant funded by us as part of our £2.7 million Research Innovation Awards scheme announced last month is trying to find new ways to stop cancer spreading to bones.